Yongin, South Korea

Chun-Ho Park

This inventor holds 5 USPTO granted patents and 2 published patent applications, plus 2 CIPO patents and 2 EPO patents. Top assignees: Je Il Pharmaceutical Co., Ltd., Wellmarker Bio Co., Ltd., Yuyu Pharma, Inc.. Active years: 2014-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Chun-Ho Park. Retrieved from https://idiyas.com/inventor/chun-ho-park-nuedh456

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 5 

% Patents Active = 100.0



Average Co-Inventor Count = 6.2

ph-index = 1

Forward Citations = 47(Granted Patents)


Company Filing History:


Years Active: 2014-2023

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Chun-Ho Park

Introduction

Chun-Ho Park is a notable inventor based in Yongin-si, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel peptides and compounds for treating various medical conditions. With a total of five patents to his name, Park's work has the potential to impact the treatment of eye diseases and other health issues.

Latest Patents

One of Chun-Ho Park's latest patents involves peptides and pharmaceutical compositions for treating eye diseases. This invention relates to novel peptides that serve as therapeutic agents, promoting tear secretion and aiding in the recovery of damaged corneas. Another significant patent focuses on thienopyridine derivatives and their pharmaceutical compositions. These compounds exhibit excellent inhibitory effects on protein kinase activity, making them useful for preventing or treating diseases associated with this activity.

Career Highlights

Throughout his career, Chun-Ho Park has worked with reputable companies in the pharmaceutical industry, including Je Il Pharmaceutical Co., Ltd. and Yuyu Pharma, Inc. His experience in these organizations has allowed him to develop and refine his innovative ideas, leading to the successful patenting of his inventions.

Collaborations

Chun-Ho Park has collaborated with several professionals in his field, including In-Hae Ye and Jong-Hee Choi. These collaborations have likely contributed to the advancement of his research and the successful development of his patented inventions.

Conclusion

Chun-Ho Park's contributions to the pharmaceutical industry through his innovative patents demonstrate his commitment to improving medical treatments. His work in developing peptides and thienopyridine derivatives showcases the potential for significant advancements in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…